Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma

SIMPLE SUMMARY: The combination of Resminostat (HDACi) and Ruxolitinib (JAKi) exerted cytotoxic effects and inhibited proliferation of CTCL cell lines (MyLa, SeAx) in vitro. The aim of the present study was to validate their antitumor effects in vivo using the chick embryo chorioallantoic membrane (...

Descripción completa

Detalles Bibliográficos
Autores principales: Karagianni, Fani, Piperi, Christina, Casar, Berta, de la Fuente-Vivas, Dalia, García-Gómez, Rocío, Lampadaki, Kyriaki, Pappa, Vasiliki, Papadavid, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870185/
https://www.ncbi.nlm.nih.gov/pubmed/35205818
http://dx.doi.org/10.3390/cancers14041070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870185/
https://www.ncbi.nlm.nih.gov/pubmed/35205818
http://dx.doi.org/10.3390/cancers14041070

Ejemplares similares